United States

People: Rockwell Medical Inc (RMTI.O)

RMTI.O on Consolidated Issue listed on NASDAQ Global Market

22 Sep 2017
Change (% chg)

$0.53 (+7.74%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Gupta, Ajay 

Dr. Ajay Gupta, M.D., is Chief Scientific Officer of Rockwell Medical Inc since June 2009. Before joining the Company, Dr. Gupta spent the prior seven years as an Associate Professor of Medicine at UCLA and Charles Drew University Schools of Medicine, Los Angeles, CA, where he had an active nephrology practice. Prior to that, Dr. Gupta served on the faculties of Henry Ford Hospital, Detroit, MI, University of Alabama, Birmingham, State University of New York, Syracuse and Washington University, St. Louis. Dr. Gupta also completed a clinical fellowship in Nephrology from Wayne State University, Detroit, Michigan and a research fellowship in Nephrology from Washington University, St. Louis, Missouri. Dr. Gupta, who is the Founder and Chairman of the Indian Society for Bone and Mineral Research, earned his MBBS degree and completed his residency in Internal Medicine from All India Institute of Medical Sciences, New Delhi. Dr. Gupta is the inventor of Triferic™ (Ferric Pyrophosphate Citrate), our FDA-approved iron maintenance therapy drug for dialysis patients. Dr. Gupta is also the inventor of intravenous iron therapy using slow continuous infusion of Ferric Pyrophosphate Citrate , including as an adjunct to parenteral nutritional admixtures. He has filed a number of patents in the areas of drugs, medical devices and diagnostic tests.

Basic Compensation

Total Annual Compensation, USD 586,128
Restricted Stock Awards, USD 1,423,500
Long-Term Incentive Plans, USD --
All Other, USD 1,228,920
Fiscal Year Total, USD 3,238,550

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Chioini


Thomas Klema


Ajay Gupta


Raymond Pratt


John Cooper


David Domzalski

As Of  30 Dec 2014